Research ArticleOriginal Article
Open Access

Incidence of sickle cell disease patients with pulmonary embolism admitted to the intensive care unit in Bahrain

Fatema H. Mandeel, Hasan M. Saeed, Ahmed H. Alsadah, Sara A. Ahmed and Redha A. Al hammam
Saudi Medical Journal August 2020, 41 (8) 802-807; DOI: https://doi.org/10.15537/smj.2020.8.25170

References

  1. ↵
    1. Bender M,
    2. Hobbs W,
    3. Pagon R,
    4. Bird T,
    5. Dolan C,
    6. Stephens Stephens K
    (2017) Sickle Cell Disease in:GeneReviews Seattle (University of Washington, Seattle (WA)).
  2. ↵
    1. Vichinsky EP,
    2. Neumayr LD,
    3. Earles AN,
    4. Williams R,
    5. Lennette ET,
    6. Dean D,
    7. et al.
    (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 342:1855–1865, [published correction appears in N Engl J Med 2000; 343: 824.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Chiang EY,
    2. Frenette PS
    (2005) Sickle cell vaso-occlusion. Hematology/Oncology Clinics of North America 19:771–784.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Platt OS,
    2. Brambilla DJ,
    3. Rosse WF,
    4. Milner PF,
    5. Castro O,
    6. Steinberg MH,
    7. et al.
    (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Powars D,
    2. Powars DR,
    3. Chan LSL,
    4. Hiti A,
    5. Ramicone E,
    6. Johnson C
    (2005) Outcome of sickle cell anemia:a 204-decade observational study of 105. Six patients outcome of sickle cell Anemia. Medicine (Baltimore) 84:363–376.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Buckwalter J,
    2. Einhorn T,
    3. O'keefe R
    (2007) Orthopedic basic science:foundation of clinical practice. Thromboembolism and pulmonary distress in the setting of orthopaedic surgery (American Academy of Orthopaedic Surgeons, Rosemont (IL)), 3rd ed, pp 105–113.
  7. ↵
    1. Stein PD,
    2. Beemath A,
    3. Meyers FA,
    4. Skaf E,
    5. Olson RE
    (2006) Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 119:897.
    OpenUrl
  8. ↵
    1. Austin H,
    2. Key NS,
    3. Benson JM,
    4. Lally C,
    5. Dowling NF,
    6. Whitsett C,
    7. et al.
    (2007) Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 110:908–912.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Burnham JM,
    2. Broussard M,
    3. Milbrandt T
    (2014) Bilateral pulmonary embolism in an adolescent with sickle cell disease and a recent total hip arthroplasty:a case report and review of the literature. Iowa Orthop J 34:107–110.
    OpenUrl
    1. Laporte S,
    2. Mismetti P,
    3. Décousus H,
    4. Uresandi F,
    5. Otero R,
    6. Lobo JL,
    7. et al.
    (2008) Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism:findings from the registro informatizado de la enfermedad tromboembolica venosa (RIETE) registry. Circulation 117:1711–1716.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Brinker MR,
    2. O'Connor DP
    1. Miller MD,
    2. Hart JA
    (2008) in Review of orthopaedics, Basic sciences, eds Brinker MR, O'Connor DP (Elsevier, Philadelphia (PA)), pp 94–97.
  12. ↵
    1. Novelli EM,
    2. Huynh C,
    3. Gladwin MT,
    4. Moore CG,
    5. Ragni MV
    (2012) Pulmonary embolism in sickle cell disease:a case-control study. J Thromb Haemost 10:760–766.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Hermann RE,
    2. Davis JH J,
    3. Holden WD
    (1961) Pulmonary embolism. A clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants. Am J Surg 102:19–28.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Al Arrayed SS,
    2. Haites,
    3. Haites N
    (1995) Features of sickle-cell disease in Bahrain. East Mediterr Health J 1:112–119.
    OpenUrl
  15. ↵
    1. Gladwin MT,
    2. Vichinsky E
    (2008) Pulmonary complications of sickle cell disease. N Engl J Med 359:2254–2265.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Al Khawaja SA,
    2. Ateya ZM,
    3. Al Hammam RA
    (2017) Predictors of mortality in adults with sickle cell disease admitted to intensive care unit in Bahrain. J Crit Care 42:238–242.
    OpenUrl
  17. ↵
    1. Noubiap JJ,
    2. Temgoua MN,
    3. Tankeu R,
    4. Tochie JN,
    5. Wonkam A,
    6. Bigna JJ
    (2018) Sickle cell disease, sickle trait and the risk for venous thromboembolism:a systematic review and meta-analysis. Thromb J 16:27.
    OpenUrlPubMed
  18. ↵
    1. Mont MA,
    2. Jacobs JJ,
    3. Boggio LN,
    4. Bozic KJ,
    5. Della Valle CJ,
    6. Goodman SB,
    7. et al.
    (2011) Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 19:768–776.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Lazo KG,
    2. Eldredge JB,
    3. Press A,
    4. Mina BA
    (2017) Pulmonary complications of sickle cell disease in the pregnant patient. Int J RespirPulm Med 4:73.
    OpenUrl
  20. ↵
    1. Brunson A,
    2. Keegan T,
    3. Mahajan A,
    4. White R,
    5. Wun T
    (2019) High incidence of venous thromboembolism recurrence in patients with sickle cell disease. Am J Hematol 94:862–870.
    OpenUrl
  21. ↵
    1. Cecchini J,
    2. Lionnet F,
    3. Djibré M,
    4. Parrot A,
    5. Stojanovic KS,
    6. Girot R,
    7. et al.
    (2014) Outcomes of adult patients with sickle cell disease admitted to the ICU:a case series. Crit Care Med 42:1629–1639.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Tawfic QA,
    2. Kausalya R,
    3. Al-Sajee D,
    4. Burad J,
    5. Mohammed AK,
    6. Narayanan A
    (2012) Adult sickle cell disease:a five-year experience of intensive care management in a university hospital in Oman. Sultan Qaboos Univ Med J 12:177–183.
    OpenUrl
  23. ↵
    1. Rosentsveyg J,
    2. Simonson JL,
    3. Chung SY,
    4. Koenig Sj,
    5. Zaidi GZ
    (2019) A retrospective study of patient demographics, therapeutic management, and outcomes of sickle cell disease in the intensive care unit. Am J Respir Crit Care Med 201:A3436.
    OpenUrl
  24. ↵
    1. Brunson A,
    2. Lei A,
    3. Rosenberg AS,
    4. White RH,
    5. Keegan T,
    6. Wun T
    (2017) Increased incidence of VTE in sickle cell disease patients:risk factors, recurrence and impact on mortality. Br J Haematol 178:319–326.
    OpenUrl
  25. ↵
    1. Josephson CD,
    2. Su LL,
    3. Hillyer KL,
    4. Hillyer CD
    (2007) Transfusion in the patient with sickle cell disease:a critical review of the literature and transfusion guidelines. Transfus Med Rev 21:118–133.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Wahl S,
    2. Quirolo KC
    (2009) Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr 21:15–21.
    OpenUrlCrossRefPubMed
    1. Alhashimi D,
    2. Fedorowicz Z,
    3. Alhashimi F,
    4. Dastgiri S
    (2010) Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev, CD007843.
  28. ↵
    1. Rosentsveyg J,
    2. Simonson JL,
    3. Chung SY,
    4. Koenig SJ,
    5. Zaidi GZ
    (2019) A retrospective study to identify early predictors of mortality in sickle cell disease patients admitted to the intensive care unit. Am J Respir Crit Care Med 199:A1675.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords